MedTrace Logo

Cancer Pain Single Nucleotide Polymorphisms (SNPs)

NCT00956878 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 243

Last updated 2014-12-24

No results posted yet for this study

Summary

Cancer pain is common in advanced cancer patients. Opioids are the mainstay of treatment in cancer pain. Responsiveness to and tolerability of opioids is, amongst others, determined by small variations in human DNA. Using blood samples from clinically well-defined cancer pain patients, the investigators are going to analyze single nucleotide polymorphisms (SNPs) in genes that are known to be involved in responsiveness to opioids and sensitivity to pain.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Joost L Jongen, MD PhD · Erasmus Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-09-30
Primary Completion
2012-12-31
Completion
2012-12-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00956878 on ClinicalTrials.gov